RxStrategies

Acquired

Strengthening Pharmacies with Smarter 340B Solutions | Pillr Health

RxStrategies was founded in 2003, is headquartered in Boca Raton, United States, lists 11–50 employees, and has $7.8M in recorded funding across 1 round.

Employees
11–50
Founded
2003
Business Model
B2B
Total Funding
$7.8M
Last Round
$7.8M Venture RoundJan 2003
Rounds
1
Acquisition Date
Sep 2019

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Comprehensive turnkey solution for Community Health Centers.

Summary

RxStrategies is a Drug Discovery company based in Boca Raton, United States, founded in 2003. It lists 11–50 employees. It has raised $7.8M in total across 1 round, most recently a $7.8M Venture Round in Jan 2003. Investors include Renovus Capital, H.I.G. Capital and Lovett Miller & Co..

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionSep 2019

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RxStrategies on Indexed.vc
<a href="https://indexed.vc/companies/rxstrategies"><img src="https://indexed.vc/api/badge/company/rxstrategies" alt="RxStrategies on Indexed.vc" width="260" height="76" /></a>